Prospective observational study investigating the impact of treatment sequence using regorafenib and FTD/TPI for metastatic colorectal cancer on overall survival (OSERO study). This is an ASCO Meeting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results